嘉和美康：2025年亏损2.53亿元

Core Viewpoint - The company Jiahe Meikang (688246) reported a significant decline in revenue and continued losses in its 2025 performance forecast, indicating challenges in the healthcare information technology sector due to external economic factors and policy changes. Financial Performance - The company achieved an operating revenue of 408 million yuan in 2025, a year-on-year decrease of 31.13% [4] - The net profit attributable to shareholders was a loss of 253 million yuan, compared to a loss of 256 million yuan in the same period last year [4] - The non-recurring net profit also showed a loss of 257 million yuan, down from a loss of 261 million yuan year-on-year [4] - The basic earnings per share were -1.84 yuan, with a weighted average return on equity of -17.69%, a decrease of 2.53 percentage points from the previous year [4][18] Valuation Metrics - The company's price-to-book ratio (LF) is approximately 2.43 times, and the price-to-sales ratio (TTM) is about 7.51 times based on the latest closing price [4] - Historical price-to-earnings ratio trends indicate significant fluctuations, with the company experiencing negative earnings, making traditional valuation methods less applicable [21] Market Conditions - The decline in revenue is attributed to reduced or delayed fiscal budget support from local governments for public hospitals' healthcare information technology construction, leading to compressed procurement demand [14] - The ongoing reform of medical insurance payments has resulted in decreased income and profit margins for public hospitals, making them more cautious in software procurement using their own funds [14]